Laboratory and clinical genetic Counselor's perspectives on the reporting of personal health risks on carrier screening reports

Carrier screening estimates the risk for an individual to be a carrier of an autosomal recessive or X-linked genetic condition. Incidentally, carrier screening may reveal personal health risks (PHR). Carrier results with PHR are "heterozygous variants which carry health risks similar to or unrelated to the disease caused by variants in a compound heterozygous, homozygous, or hemizygous configuration" (Sagaser et al., 2023, Journal of Genetic Counseling, 32, 540). Despite previous research identifying the carrier screening laboratory report as the most frequently utilized resource when providing post-test counseling for PHR, genetic counselors' preferences and expectations regarding PHR reporting have not been investigated. We developed a 20-item survey using five-point Likert scales and free-response questions related to the format and content of a laboratory report when PHR is identified. Participants were recruited through the NSGC Student Research Survey Listserv and included 48 clinical and eight laboratory genetic counselors. Most participants had neutral (39%) or low satisfaction (48%) with the current reporting of PHR. Participant-free responses highlighted a lack of consistency in how PHR is reported. Most participants (79%) agreed that reports should include clear management recommendations regarding PHR follow-up for providers, such as suggestions for specialty referrals or professional guidelines relevant to risks associated with the specific gene. There was a wide variation in responses regarding whether patients should be able to opt-out of PHR information on carrier screening panels. Free responses collected suggest the need for further investigation and clarification regarding an opt-out policy concerning logistics and consent. PHR for carriers is a nuanced topic, and reporting these risks requires careful consideration. The results of this study provide guidance as to how genetic counselors desire to see PHR reported on carrier reports.

Authors

Institutions

Publication Details

Journal
Journal of Genetic Counseling
Published
2025-04-30
DOI
https://doi.org/10.1002/jgc4.70009
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Laboratory and clinical genetic Counselor's perspectives on the reporting of personal health risks on carrier screening reports

Kristen Fishler, S. Dana Hubbard, Alexandra Hankewycz
Journal of Genetic Counseling
Cystic Fibrosis Research Advances
article

Laboratory and clinical genetic Counselor's perspectives on the reporting of personal health risks on carrier screening reports

Kristen Fishler, S. Dana Hubbard, Alexandra Hankewycz
article en

Abstract

Carrier screening estimates the risk for an individual to be a carrier of an autosomal recessive or X-linked genetic condition. Incidentally, carrier screening may reveal personal health risks (PHR). Carrier results with PHR are "heterozygous variants which carry health risks similar to or unrelated to the disease caused by variants in a compound heterozygous, homozygous, or hemizygous configuration" (Sagaser et al., 2023, Journal of Genetic Counseling, 32, 540). Despite previous research identifying the carrier screening laboratory report as the most frequently utilized resource when providing post-test counseling for PHR, genetic counselors' preferences and expectations regarding PHR reporting have not been investigated. We developed a 20-item survey using five-point Likert scales and free-response questions related to the format and content of a laboratory report when PHR is identified. Participants were recruited through the NSGC Student Research Survey Listserv and included 48 clinical and eight laboratory genetic counselors. Most participants had neutral (39%) or low satisfaction (48%) with the current reporting of PHR. Participant-free responses highlighted a lack of consistency in how PHR is reported. Most participants (79%) agreed that reports should include clear management recommendations regarding PHR follow-up for providers, such as suggestions for specialty referrals or professional guidelines relevant to risks associated with the specific gene. There was a wide variation in responses regarding whether patients should be able to opt-out of PHR information on carrier screening panels. Free responses collected suggest the need for further investigation and clarification regarding an opt-out policy concerning logistics and consent. PHR for carriers is a nuanced topic, and reporting these risks requires careful consideration. The results of this study provide guidance as to how genetic counselors desire to see PHR reported on carrier reports.

Journal of Genetic CounselingVol. 34(3)
Nebraska Medical Center (US), University of Nebraska Medical Center (US)
Openalex Percentile: Top 86%
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.